Long-term efficacy of lurasidone in antipsychotic-naive vs. antipsychotic-exposed adolescents with schizophrenia: Post-hoc analysis of a two year, open-label study

被引：0
|
作者：
Correll, C. [1 ,2 ]
Goldman, R. [3 ]
Tocco, M. [4 ]
Pikalov, A. [5 ]
Loebel, A. [4 ]
机构：
[1] Zucker Hillside Hosp, Hofstra Northwell Sch Med, Glen Oaks, NY USA
[2] Charite, Psychiat Mol Biol & Child & Adolescent Psychiat, Berlin, Germany
[3] Sunovion Pharmaceut Inc, Res & Dev, Marlborough, MA USA
[4] Sunovion Pharmaceut Inc, Med Affairs, Marlborough, MA USA
[5] Sunovion Pharmaceut Inc, Med Affairs, Ft Lee, NJ USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2019年 / 29卷
关键词：
D O I：
10.1016/j.euroneuro.2019.09.157
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.102
引用
收藏
页码：S88 / S88
页数：1
相关论文
共 50 条
  • [31] Long-Term Efficacy and Safety of Brexpiprazole in Elderly Japanese Patients with Schizophrenia: A Subgroup Analysis of an Open-Label Study
    Inada, Ken
    Yamada, Sakiko
    Akiyoshi, Hisashi
    Kojima, Yoshitsugu
    Iwashita, Shuichi
    Ishigooka, Jun
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2020, 16 : 2267 - 2275
  • [32] A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendation
    Anand, Ernie
    Berggren, Lovisa
    Deix, Claudia
    Toth, Agoston
    McDonnell, David P.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 1349 - 1357
  • [33] Effectiveness of long-term treatment with lurasidone in children and adolescents with bipolar depression: week 28 results of a 2-year open-label extension study
    Chang, K.
    DelBello, M.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    BIPOLAR DISORDERS, 2018, 20 : 65 - 65
  • [34] Safety of long-term treatment with lurasidone in children and adolescents with bipolar depression: week 28 results of a 2-year open-label extension study
    Chang, K.
    DelBello, M.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    BIPOLAR DISORDERS, 2018, 20 : 66 - 66
  • [35] Assessment of the long-term efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: Post hoc analysis of open-label extension studies
    Pina-Garza, J. Eric
    Villanueva, Vicente
    Rosenfeld, William
    Yoshinaga, Harumi
    Patten, Anna
    Malhotra, Manoj
    EPILEPSY & BEHAVIOR, 2022, 135
  • [36] Assessment of the Long-Term Efficacy and Safety of Adjunctive Perampanel in Adolescent Patients: Post Hoc Analysis of Open-Label Extension (OLEx) Studies
    Pina-Garza, J. Eric
    Villanueva, Vicente
    Rosenfeld, William
    Yoshinaga, Harumi
    Bibbiani, Francesco
    Patten, Anna
    Williams, Betsy
    Laurenza, Antonio
    NEUROLOGY, 2018, 90
  • [37] Assessment of the Long-Term Efficacy and Safety of Adjunctive Perampanel in Adolescent Patients: Post Hoc Analysis of Open-Label Extension (OLEX) Studies
    Pina-Garza, J. E.
    Villanueva, V.
    Rosenfeld, W.
    Yoshinaga, H.
    Bibbiani, F.
    Patten, A.
    Williams, B.
    Laurenza, A.
    EPILEPSIA, 2018, 59 : S77 - S77
  • [38] Long-Term Safety and Efficacy of Blonanserin Oral Tablet in Adolescents with Schizophrenia: A 52-Week, Multicenter, Open-Label Extension Study
    Saito, Takuya
    Hyodo, Yohei
    Sakaguchi, Reiko
    Nakamura, Hiroshi
    Ishigooka, Jun
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2022, 32 (01) : 24 - 35
  • [39] Sustained Remission With Adjunctive Brexpiprazole in Major Depressive Disorder: Post Hoc Analysis of a Long-Term, Open-Label, Extension Study
    Baker, Ross A.
    Weiss, Catherine
    Meehan, Stine R.
    Zhang, Peter
    Hobart, Mary
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S307 - S307
  • [40] Safety and effectiveness of long-term treatment with lurasidone in children and adolescents with bipolar depression: A 6-month interim analysis of a 2-year open-label extension study
    Chang, K.
    Tocco, M.
    Goldman, R.
    Pikalov, A.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2018, 48 : S81 - S82
12345